foxo4-dri senolytic 2023 2024 study Peptide Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes PDF) Senolytic Peptide FOXO4-DRI Selectively

Synovial Fibroblast-Derived Exosomal microRNA-106b Suppresses Chondrocyte Proliferation and Migration in Rheumatoid Arthritis via Down-Regulation of PDK4

This trajectory, inflammation first and then structural, is what distinguishes a well-run TB-500 protocol from a short-term anti-inflammatory course that produces temporary relief without addressing the underlying repair

10.1038/s41598-017-16637-2 Sci

Start: 600 mcg total daily (300 mcg each peptide) for Weeks 12

Yes, often stacked with CJC-1295 or NAD+ IV therapy for enhanced results Not yet for weight loss, but its widely used in functional medicine

The peptide also tolerates lyophilisation and reconstitution without measurable loss of activity, and stable storage at -20C exceeds 24 months in published shelf-life data